Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression

Journal of Controlled Release

Volumn 232, Issue , 2016, Pages 131-142

  Lei, Yifeng ^a   Hamada, Yoh ^b   Li, Jun ^a   Cong, Liman ^b   Wang, Nuoxin ^a   Li, Ying ^a   Zheng, Wenfu ^a   Jiang, Xingyu ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug delivery; Ferritin nanoparticles; Nervous microenvironment; Pancreatic cancer

Indexed keywords

BRAIN; DRUG DELIVERY; NANOPARTICLES; NEURONS; TUMORS;

ANTI-CANCER THERAPIES; CONTROLLED RELEASE; MICROENVIRONMENTS; PANCREATIC CANCERS; PANCREATIC TUMORS; PASSIVE TARGETING; TRANSFERRIN RECEPTOR 1; TRIGGERED DRUG RELEASE;

DISEASES;

ATROPINE; CARBACHOL; CD71 ANTIGEN; DOXORUBICIN; FERRITIN NANOPARTICLE; GEMCITABINE; NANOCARRIER; NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FERRITIN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RELEASE; METABOLISM; NUDE MOUSE; PANCREAS TUMOR; PHARMACOKINETICS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ATROPINE; CARBACHOL; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FERRITINS; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NANOPARTICLES; NEUROGENESIS; PANCREATIC NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84964632207     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.03.023     Document Type: Article

References (53)

1. A. Stathis, and M.J. Moore Advanced pancreatic carcinoma: current treatment and future challenges Nat. Rev. Clin. Oncol. 7 2010 163 172
2. C. Magnon, S.J. Hall, J. Lin, X. Xue, L. Gerber, S.J. Freedland, and P.S. Frenette Autonomic nerve development contributes to prostate cancer progression Science 341 2013 1236361
3. C.M. Zhao, Y. Hayakawa, Y. Kodama, S. Muthupalani, C.B. Westphalen, G.T. Andersen, A. Flatberg, H. Johannessen, R.A. Friedman, B.W. Renz, A.K. Sandvik, V. Beisvag, H. Tomita, A. Hara, M. Quante, Z. Li, M.D. Gershon, K. Kaneko, J.G. Fox, T.C. Wang, and D. Chen Denervation suppresses gastric tumorigenesis Sci. Transl. Med. 6 2014 250ra115
4. C.S. Scanlon, R. Banerjee, R.C. Inglehart, M. Liu, N. Russo, A. Hariharan, E.A. van Tubergen, S.L. Corson, I.A. Asangani, C.M. Mistretta, A.M. Chinnaiyan, and N.J. D'Silva Galanin modulates the neural niche to favour perineural invasion in head and neck cancer Nat. Commun. 6 2015 6885
5. S.C. Peterson, M. Eberl, A.N. Vagnozzi, A. Belkadi, N.A. Veniaminova, M.E. Verhaegen, C.K. Bichakjian, N.L. Ward, A.A. Dlugosz, and S.Y. Wong Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches Cell Stem Cell 16 2015 400 412
6. H.S. Venkatesh, T.B. Johung, V. Caretti, A. Noll, Y.J. Tang, S. Nagaraja, E.M. Gibson, C.W. Mount, J. Polepalli, S.S. Mitra, P.J. Woo, R.C. Malenka, H. Vogel, M. Bredel, P. Mallick, and M. Monje Neuronal activity promotes glioma growth through neuroligin-3 secretion Cell 161 2015 803 816
7. P. Jobling, J. Pundavela, S.M.R. Oliveira, S. Roselli, M.M. Walker, and H. Hondermarck Nerve-cancer cell cross-talk: a novel promoter of tumor progression Cancer Res. 75 2015 1777 1781
8. D.F. Quail, and J.A. Joyce Microenvironmental regulation of tumor progression and metastasis Nat. Med. 19 2013 1423 1437
9. A.A. Bapat, G. Hostetter, D.D. Von Hoff, and H. Han Perineural invasion and associated pain in pancreatic cancer Nat. Rev. Cancer 11 2011 695 707
10. I.E. Demir, G.O. Ceyhan, F. Liebl, J.G. D'Haese, M. Maak, and H. Friess Neural invasion in pancreatic cancer: the past, present and future Cancers 2 2010 1513 1527
11. T. Kiba Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis - recent developments Pancreas 29 2004 E51 E58
12. I. Makino, H. Kitagawa, T. Ohta, H. Nakagawara, H. Tajima, I. Ohnishi, H. Takamura, T. Tani, and M. Kayahara Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses Pancreas 37 2008 358 365
13. G. Burnstock Neurotransmitters and trophic factors in the autonomic nervous-system J. Physiol. Lond. 313 1981 1 35
14. L.S. Satin, and T.A. Kinard Neurotransmitters and their receptors in the islets of Langerhans of the pancreas - what messages do acetylcholine, glutamate, and GABA transmit Endocrine 8 1998 213 223
15. E.R. Spindel Muscarinic receptor agonists and antagonists: effects on cancer Handb. Exp. Pharmacol. 2012 451 468
16. N. Shah, S. Khurana, K. Cheng, and J.P. Raufman Muscarinic receptors and ligands in cancer Am. J. Physiol. Cell Physiol. 296 2009 C221 C232
17. M.S. Ackerman, W.R. Roeske, R.J. Heck, and M. Korc Identification and characterization of muscarinic receptors in cultured human pancreatic-carcinoma cells Pancreas 4 1989 363 370
18. J.L. Chien, and J.R. Warren Muscarinic receptor coupling to intracellular calcium release in rat pancreatic acinar carcinoma Cancer Res. 46 1986 5706 5714
19. R.A. Harvey, and P.C. Champe Lippincott Illustrated Reviews: Pharmacology (4th Edition) 2009 Lippincott Williams & Wilkins
20. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
21. Y. Tian, H.M. Wang, Y. Liu, L.N. Mao, W.W. Chen, Z.N. Zhu, W.W. Liu, W.F. Zheng, Y.Y. Zhao, D.L. Kong, Z.M. Yang, W. Zhang, Y.M. Shao, and X.Y. Jiang A peptide-based nanofibrous hydrogel as a promising DNA Nanovector for optimizing the efficacy of HIV Vaccine Nano Lett. 14 2014 1439 1445
22. K. Fan, C. Cao, Y. Pan, D. Lu, D. Yang, J. Feng, L. Song, M. Liang, and X. Yan Magnetoferritin nanoparticles for targeting and visualizing tumour tissues Nat. Nanotechnol. 7 2012 459 464
23. M. Liang, K. Fan, M. Zhou, D. Duan, J. Zheng, D. Yang, J. Feng, and X. Yan H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection Proc. Natl. Acad. Sci. U. S. A. 111 2014 14900 14905
24. C.Q. Cao, X.X. Wang, Y. Cai, L. Sun, L.X. Tian, H. Wu, X.Q. He, H. Lei, W.F. Liu, G.J. Chen, R.X. Zhu, and Y.X. Pan Targeted in vivo imaging of microscopic tumors with ferritin- based nanoprobes across biological barriers Adv. Mater. 26 2014 2566 2571
25. E.C. Theil Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms Annu. Rev. Biochem. 56 1987 289 315
26. M. Uchida, M.L. Flenniken, M. Allen, D.A. Willits, B.E. Crowley, S. Brumfield, A.F. Willis, L. Jackiw, M. Jutila, M.J. Young, and T. Douglas Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles J. Am. Chem. Soc. 128 2006 16626 16633
27. X. Lin, J. Xie, G. Niu, F. Zhang, H.K. Gao, M. Yang, Q.M. Quan, M.A. Aronova, G.F. Zhang, S. Lee, R. Leaprnan, and X.Y. Chen Chimeric ferritin nanocages for multiple function loading and multimodal imaging Nano Lett. 11 2011 814 819
28. Z.P. Zhen, W. Tang, H.M. Chen, X. Lin, T. Todd, G. Wang, T. Cowger, X.Y. Chen, and J. Xie RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors ACS Nano 7 2013 4830 4837
29. T.R. Daniels, E. Bernabeu, J.A. Rodriguez, S. Patel, M. Kozman, D.A. Chiappetta, E. Holler, J.Y. Ljubimova, G. Helguera, and M.L. Penichet The transferrin receptor and the targeted delivery of therapeutic agents against cancer Biochim. Biophys. Acta Gen. Subj. 1820 2012 291 317
30. L. Li, C.J. Fang, J.C. Ryan, E.C. Niemi, J.A. Lebron, P.J. Bjorkman, H. Arase, F.M. Torti, S.V. Torti, M.C. Nakamura, and W.E. Seaman Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 Proc. Natl. Acad. Sci. U. S. A. 107 2010 3505 3510
31. E.N. Marieb Essentials of Human Anatomy and Physiology 10th ed. 2012
32. E.D.B. Clark Refolding of recombinant proteins Curr. Opin. Biotechnol. 9 1998 157 163
33. I.F. Tannock, and D. Rotin Acid pH in tumors and its potential for therapeutic exploitation Cancer Res. 49 1989 4373 4384
34. L.E. Gerweck, and K. Seetharaman Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res. 56 1996 1194 1198
35. J.L. Zhang, W. Jin, X.Q. Wang, J.C. Wang, X.A. Zhang, and Q.A. Zhang A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models Mol. Pharm. 7 2010 1159 1168
36. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
37. M.J. Carden, J.Q. Trojanowski, W.W. Schlaepfer, and V.M.Y. Lee 2-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns J. Neurosci. 7 1987 3489 3504
38. S. Elmasry, and S.A.H. Khalil Adsorption of atropine and hyoscine on magnesium trisilicate J. Pharm. Pharmacol. 26 1974 243 248
39. G.M. Yan, S.Z. Lin, R.P. Irwin, and S.M. Paul Activation of muscarinic cholinergic receptors blocks apoptosis of cultured cerebellar granule neurons Mol. Pharmacol. 47 1995 248 257
40. S.C. Yang, H.X. Ge, Y. Hu, X.Q. Jiang, and C.Z. Yang Doxorubicin-loaded poly(butylcyanoacrylate) nanoparticles produced by emulsifier-free emulsion polymerization J. Appl. Polym. Sci. 78 2000 517 526
41. E. Ryschich, G. Huszty, H.P. Knaebel, M. Hartel, M.W. Büchler, and J. Schmidt Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas Eur. J. Cancer 40 2004 1418 1422
42. P. Song, H.S. Sekhon, A. Lu, J. Arredondo, D. Sauer, C. Gravett, G.P. Mark, S.A. Grando, and E.R. Spindel M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion Cancer Res. 67 2007 3936 3944
43. S.J. Miknyoczki, D. Lang, L.Y. Huang, A.J.P. Klein-Szanto, C.A. Dionne, and B.A. Ruggeri Neurotrophins and trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior Int. J. Cancer 81 1999 417 427
44. Z.W. Zhu, H. Friess, F.F. diMola, A. Zimmermann, H.U. Graber, M. Korc, and M.W. Buchler Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer J. Clin. Oncol. 17 1999 2419 2428
45. M.B. Schneider, J. Standop, A. Ulrich, U. Wittel, H. Friess, A. Andren-Sandberg, and P.M. Pour Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer J. Histochem. Cytochem. 49 2001 1205 1210
46. Z.W. Zhu, H. Friess, L. Wang, T. Bogardus, M. Korc, J. Kleeff, and M.W. Buchler Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells Clin. Cancer Res. 7 2001 105 112
47. R.E. Stopczynski, D.P. Normolle, D.J. Hartman, H.Q. Ying, J.J. DeBerry, K. Bielefeldt, A.D. Rhim, R.A. DePinho, K.M. Albers, and B.M. Davis Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma Cancer Res. 74 2014 1718 1727
48. Z.W. Zhu, J. Kleeff, H. Kayed, L. Wang, M. Korc, M.W. Buchler, and H. Friess Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells Mol. Carcinog. 35 2002 138 147
49. P.X. Liu, H.L. Cheng, T.M. Roberts, and J.J. Zhao Targeting the phosphoinositide 3-kinase pathway in cancer Nat. Rev. Drug Discov. 8 2009 627 644
50. M. Mancino, E. Ametller, P. Gascon, and V. Almendro The neuronal influence on tumor progression BBA-Rev Cancer 1816 2011 105 118
51. G.O. Ceyhan, I.E. Demir, B. Altintas, U. Rauch, G. Thiel, M.W. Muller, N.A. Giese, H. Friess, and K.H. Schafer Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells Biochem. Biophys. Res. Commun. 374 2008 442 447
52. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
53. A.C. Kruse, B.K. Kobilka, D. Gautam, P.M. Sexton, A. Christopoulos, and J. Wess Muscarinic acetylcholine receptors: novel opportunities for drug development Nat. Rev. Drug Discov. 13 2014 549 560